Fujian Medical University Union Hospital

This study tests whether adding silibinin (a liver-protecting supplement from milk thistle) to standard chemotherapy can improve outcomes for people with newly diagnosed acute myeloid leukemia (AML). About 100 adults will receive either standard chemo or standard chemo plus silib…

This study tests a personalized vaccine made from a patient's own leukemia cells to prevent the cancer from returning after standard chemotherapy. About 90 adults with acute myeloid leukemia (AML) who are in remission will receive the vaccine during or after consolidation therapy…

This study tests whether tiny particles from umbilical cord stem cells, called exosomes, can help regrow hair in men with male pattern baldness. The exosomes are delivered into the scalp using a microneedle device. The trial will enroll 18 men and measure changes in hair density …

This study tests whether a combination of two drugs (zanidatamab and tislelizumab) plus chemotherapy can shrink tumors enough to avoid bladder removal in people with HER2-positive muscle-invasive bladder cancer. About 25 adults with stage 2 to 4a cancer will receive the treatment…

This study tests a treatment plan based on a biomarker (CPS score) given before surgery for people with a certain type of esophageal cancer. About 90 adults with resectable, locally advanced esophageal squamous cell carcinoma will receive this tailored neoadjuvant therapy. The ma…

This study compares a new, personalized biopsy method that uses fewer needle samples to the standard approach for diagnosing prostate cancer. The goal is to see if the new method can detect dangerous cancers just as well while reducing pain, bleeding, and infection risk. About 33…

This study tests whether a non-invasive treatment called repetitive transcranial magnetic stimulation (rTMS) can improve thinking and memory in people with mild-to-moderate Alzheimer's disease. Researchers will enroll 66 participants and use brain scans to understand how the trea…

This study looks at whether a protein called leptin, found in bone marrow fluid, can help predict how well chemotherapy will work in adults with acute myeloid leukemia (AML). Researchers will measure leptin levels in 86 newly diagnosed patients before treatment and compare them t…